The intrauterine growth restriction (fetuses classified as SPA) may also be explained by maternal hyperglycemia above 300 mg/dL (severe diabetes), which leads to depletion of functional fetal pancreas with reduced insulin production, causing an insult to fetal growth [15,48], and thus a higher proportion of fetuses SPA. The gene discussed is INS; the disease is diabetes mellitus.